Depakote
Product Images NDC 54868-5525

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Depakote (NDC 54868-5525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Depakote® Er Divalproex Sodium Extended-release Tablets 500 mg Package Label (4959)

Depakote ER is a medication prescribed by physicians for total care. The package contains 6 tablets of 500mg each. The rest of the text is not available as it contains unreadable characters.*

FDA Label Image

Depakote® Er Divalproex Sodium Extended-release Tablets 250 mg Package Label (5525)

FDA Label Image

Chemical Structure Of Divalproex Sodium (Depakote Er 01)

FDA Label Image

Figure 3 (Depakote Er 02)

FDA Label Image

Figure 1 (Depakote Er 03)

The given text describes a graph or chart showing the percentage reduction in CPS (cycles per second) rate for patients taking Depakote compared to those taking placebo. The graph indicates a 100% reduction for Depakote and a 50% reduction for placebo. It also suggests an improvement in the condition of the patients taking Depakote.*

FDA Label Image

Figure 2 (Depakote Er 04)

This text appears to be a chart showing the percentage reduction in CPS rate for High Dose DEPAKOTE vs. Low Dose DEPAKOTE. It also shows the percentage of patients who experienced improvement, no change, or worsening.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.